GlassScriptPhysician profile
Evan Ross Goodman
NPI 1841685120
$14,170.38
in general payments reported to CMS, 2019-2025
33 companies · $1,594 in 2025
The $1,594 reported for 2025 was more than what 78% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,888 · 2020: $948 · 2021: $1,090 · 2022: $744 · 2023: $1,114 · 2024: $1,794 · 2025: $1,594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,730 · Travel and Lodging: $771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,729.68 |
| Travel and Lodging | $771.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $4,754.22 | 2019-2020 | |
| Abbott Laboratories | $2,304.75 | 2019-2024 | Eterna |
| Boston Scientific Corporation | $1,467.16 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Mml US, INC. | $1,247.30 | 2022-2023 | Reactiv8 |
| Medtronic, INC. | $1,102.97 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Spr Therapeutics, INC | $802.70 | 2022-2025 | Sprint Pns System |
| Relievant Medsystems, INC. | $414.64 | 2020 | |
| Saluda Medical Americas, INC. | $293.40 | 2025 | Evoke |
| Stimwave Technologies Incorporated | $235.62 | 2020-2022 | |
| Vertos Medical, INC. | $216.51 | 2022-2024 | Mild Device Kit |
| Averitas Pharma INC. | $144.07 | 2024-2025 | Qutenza |
| Vertiflex, INC. | $112.09 | 2019 | |
| Curonix LLC | $106.90 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $106.22 | 2025 | Vyrsa V1, Senza |
| Nalu Medical, INC. | $104.46 | 2023-2025 | Nalu Neurostimulation System |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $100.60 | 2024 | Orthovisc, Monovisc |
| Tersera Therapeutics LLC | $74.22 | 2023-2025 | Prialt |
| Painteq LLC | $70.57 | 2023-2024 | Painteq |
| Pacira Therapeutics, INC. | $64.65 | 2021 | |
| Nevro Corp. | $61.89 | 2021-2024 | Senza |
| Si-Bone, INC. | $60.86 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $52.57 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $48.27 | 2024-2025 | Iovera, Zilretta, Exparel |
| Masimo Corporation | $37.49 | 2021 | |
| Ibsa Pharma INC. | $25.33 | 2025 | Tirosint, Licart, Flector |
| Neuronetics, INC. | $23.95 | 2023 | Neurostar Tms Therapy System |
| Abbvie INC. | $22.78 | 2024 | |
| Collegium Pharmaceutical, INC. | $21.19 | 2020 | |
| Amgen INC. | $21.05 | 2022 | |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.25 | 2025 | Relistor |
| Stratus Medical, LLC | $16.84 | 2023 | Nimbus |
| Azurity Pharmaceuticals, INC. | $13.86 | 2024 | Horizant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Goodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.